A new machine-learning-based approach to mapping real-time tumor metabolism in brain cancer patients, developed at the ...

After radiation therapy, certain cancer patients face a lingering question: Is a troubling lesion a return of the cancer, or ...

Researchers at the University of Michigan developed a machine learning–based digital twin to map real-time tumor metabolism ...

Thousands of men suffering from prostate cancer are set to gain access to a life-extending drug on the NHS following a ...

Results demonstrate a significant survival benefit in the cTMB-H / HRP subset: median OS of almost 6 years (68 months) with Vigil vs. less than 2 years (19 months) for placebo (HR=0.23; p=0.008)7-year ...

To opt-out click on “Do Not Sell or Share My Personal Information” in the website footer, or to learn more, please visit our ...

The first line of treatment for cancer is, whenever possible, to remove the cancerous tissue from the body. Though often ...

Investing.com -- ImmunityBio (NASDAQ:IBRX) stock rose 6% Wednesday morning after the company announced that Saudi Arabia’s Food and Drug Authority granted accelerated approval for its ANKTIVA therapy ...

Johnson & Johnson (NYSE:JNJ), a worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI® ...

Currently pursuing a doctorate in pharmacy, Hii serves as the president of PharmSC, a student-run clinic located inside the ...

A new computer model could help predict and improve antibody drug formulations. The goal is for patients to be able to ...